Status: Recruiting
Efficacy and Safety of the CG-100 Intraluminal Bypass Device
A randomized trial to assess the safety and efficacy of CG-100 for reducing stoma creation rate in subjects undergoing mesorectal excision.
Participants needed: 250
Trial details
Age: 22-70Biological sex: AllType: InterventionalSponsor: Colospan Ltd.Updated: Oct 23, 2025Locations: 14
Eligibility criteria
The patient is willing to comply with protocol-specified follow-up evaluations [+6]
Patient has local or systemic infection at the time of intervention (e.g., perit... [+15]